Created in 2009 (Switzerland), NORVIPREN own 2951 sister brands and 17477 competing brands. NORVIPREN is a brand of NOVARTIS N, listed on the stock exchange of Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. NORVIPREN belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(NORVIPREN)
over 5 years*
CHF 100.35